Biobanking Market to 2022 – Growing Steady at 7.8% CAGR and Projected to Reach US$ 2.69 Billion

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Biobanking Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Biobanking market spread across 171 Pages, profiling 13 companies and supported with tables and figures.

Download Free Brochure of “Biobanking Market” at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1148472

Table of Contents
• Introduction
• Research Methodology
• Executive Summary
• Premium Insights
• Market Overview
• Global Biobanking Market, By Product and Service
• Global Biobanking Market, By Sample Type
• Global Biobanking Market, By Storage Type
• Global Biobanking Market, By Application
• Global Biobanking Market, By Region
• Competitive Landscape
• Company Profiles
• Appendix

The Biobanking Market is expected to reach US$ 2.69 Billion by 2022 from US$ 1.85 Billion in 2017, at a CAGR of 7.8%. Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research, and the growing need for cost-effective drug discovery and development.

“Automated storage is expected to register the highest CAGR during the forecast period”
The biobanking market is classified by storage type into manual and automated storage. The automated storage type segment is expected to grow at a higher rate during the forecast period. This is attributed to launch of new and advanced automated storage equipment and increasing demand for the quality storage of samples.

“Asia-Pacific is estimated to grow at the highest CAGR during the forecast period”
Geographically, the biobanking market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the large population in China and India, increasing research in regenerative medicine, and improving life sciences research infrastructure in the region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 70% and Tier 2 – 30%
• By Designation – C level – 62%, Director level – 21%, Others – 17%
• By Region – North America –50%, Europe – 20%, Asia- Pacific – 30%

The Study Objectives of this report are:

• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

• To define, describe, and forecast the Biobanking Market by product and service, sample type, storage type, application, and region

• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)

• To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

• To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

• To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the market

#Target Audience/Stakeholders for Biobanking Market: Biobanking associations,Research & consulting firms,Distributors of research products,Contract manufacturers of biobanking equipment and consumables,Research institutes and clinical research organizations (CROs),Venture capitalists,Government associations.

A Discount can be asked before order a copy of Biobanking Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1148472

#Top Key Players in the “Biobanking Market” include are Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.), Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd (U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.).

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

This release was published on openPR.